Keep up to date with our fundraising progress, new initiatives, relevant news articles and updates from the team at The Rare Initiative.
A message from our founder.
A revolution in cancer detection and treatment.
Ivosidenib approved for use in CCA.
MGH discovers link between two FGFR inhibitors.
An IDH1 breakthrough for CCA.
Featuring Dr Lipika Goyal.
Join our fundraising movement.
Future projections of cancer burden.
Breakthrough Designation for Futibatinib.
A moment of opportunity.
Start your own WigOut fundraiser.
Follow us @therareinitiative.
Click here to visit our page.
See our live fundraising total.
© 2021 The RARE Initiative.
Henri & Belinda Termeer Center
for Targeted Therapies
Mass General Cancer Center
55 Fruit Street, Boston MA